Company intelligence / Profile preview

Denovo Neuroscience

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

Denovo Neuroscience is a clinical-stage biopharmaceutical company focused on developing precision medicines for central nervous system (CNS) disorders. The company leverages its proprietary, big-data-enabled Denovo Genomic Marker (DGM™) biomarker discovery platform to retrospectively identify genetic biomarkers from archived clinical samples, allowing them to rescue and advance previously discontinued therapies. Denovo's lead asset is DB104 (liafensine), a first-in-class triple reuptake inhibitor in Phase 3 development for treatment-resistant depression (TRD) guided by the ANK3 genetic biomarker. Its broader CNS pipeline includes DB103 (pomaglumetad methionil) for schizophrenia and psychosis, DB105 for Alzheimer's disease, and DB109 for Alzheimer's disease.

Therapeutic areas: PsychiatryNeurology
Modalities: Small molecule
Industry: Biotech

Partnerships

OrygenChuang Yi Global Asset Management Co., Ltd.

Beyond the preview

Go deeper on Denovo Neuroscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Denovo Neuroscience.

Explore the full profile